Nik123

An upsurge in aquaculture farming and rising prevalence of diseases & parasites will spur aquaculture healthcare market growth. Poor water quality with low oxygen content has augmented the incidences of disease among aquatic animals, which has raised the demand for aquaculture healthcare products. Mounting demand for fish protein is a key impetus for the growth of the market. As per the Food and Agriculture Organization (FAO), in 2016, the per capita consumption of fishes doubled to over 20 kg. Increased demand for shrimp and fish along with overfishing of other wild varieties of fishes is likely to translate into substantial aquaculture healthcare industry demand.

According to a research study conducted by Global Market Insights, Inc., aquaculture healthcare market size is anticipated to surpass $1 billion by 2026.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4536

Elaborating on the product spectrum, aquaculture healthcare market is segmented into vaccines, drugs, and medicated feed additives. In 2019, the drug segmented accounted for around 55.5% share in the total aquaculture healthcare industry. The drug segment comprises anti-infective, parasiticides, and anti-inflammatory drugs. Prevalence of parasites and diseases has raised among farmed fish, which has encouraged research & development for innovative products to treat parasites, such as sea-lice.

Aquatic animals are prone to various infections, including viral, fungal, bacterial, and parasitic infections. In 2019, the parasitic infections segment stood at $148.3 million. The segmental growth can be accredited to the rising vulnerability of aquatic animals towards parasites, such as sea fleas and sea lice. Also, introduction of several innovative products for the treatment of such infections will stimulate demand for anti-parasitic therapeutics in the ensuing years.

On the basis of species, aquaculture healthcare industry can be divided into crustaceans and fishes. Aquatic animals, such as shrimps and prawns are placed under the crustacean segment, which is expected to observe a 6.5% CAGR over 2020-2026. The growth will stem from the intensifying demand for shrimps and prawns and the flourishing large crustaceans business in South Asian nations.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4536

On the basis of the distribution channel, aquaculture healthcare market is bifurcated into online stores, retail/aqua stores, and distributors. The Retail/aqua stores segment is likely to grow at a CAGR of 5.9% over the forecast period due to the easy availability of several therapeutic solutions at retail stores. Also, specialty products for aquatic animals are easily accessible at aqua stores, which will proliferate segmental growth.

From a regional perspective, in 2019, North America aquaculture healthcare industry size was valued at $75.8 million. Canada was at the forefront of North America market owing to the presence of major industry players in the country. Moreover, countries in North America are witnessing large consumption of seafood, which will augment North America aquaculture healthcare market size.

Browse report summary @ https://www.gminsights.com/industry-analysis/aquaculture-healthcare-market

Amplifying demand for aquaculture healthcare products and services has encouraged various key market players to invest in capacity expansion to retain potential customer base. For example, in December 2017, PharmaQ announced the inauguration of a new manufacturing facility in Norway to satisfy the massive demand for aquaculture vaccines in the country. A few more notable aquaculture healthcare industry players are Merck, Zoetis, Elanco, Vetoquinol, Archer Daniels Midland Corporation, Benchmark PLC, and DuPont. These companies are focusing on the adoption of various inorganic business strategies, such as collaborations, mergers, and acquisitions to gain a competitive advantage over the market.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Increasing demand for minimally invasive surgical procedures, along with easy availability of advanced treatments is likely to drive U.S. ambulatory surgical centers market outlook.

The growing prevalence of chronic diseases, such as cancer, obesity, diabetes, asthma, rheumatoid arthritis, and cardiac diseases has resulted in increased number of surgeries. According to the CDC (Centers for Disease Control and Prevention), about 93.3 million adults in the United States were affected by obesity in 2016. The aforesaid has fueled the demand for bariatric surgeries across the country.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4520

Increasing pace of population aging along with rising prevalence of chronic diseases across the country will act as a high impact rendering factor for ambulatory surgical centers industry expansion. Rising incidence of road accidents may also support business scenario. Moreover, low-cost treatment & services and favorable reimbursement policies will further fuel the demand for ambulatory surgical centers over the coming years. U.S. ambulatory surgical centers market size is forecast to cross the USD 37 billion mark by 2026.

Ambulatory surgical centers in U.S. have witnessed numerous improvements and advancements in recent years. Companies operating in the industry are focused on advancing medical services to augment patient experience. Conduction of minimally invasive procedures in ambulatory surgical centers are aligned with various advantages, such as reduced pain, bleeding, shorter hospital stays, reduced hospital-acquired infections, and lesser trauma to muscles & tissues.  These positive factors are likely to bolster the demand for ambulatory surgeries, hence supplementing U.S. ambulatory surgical centers market share.

By ownership, U.S. ambulatory surgical centers industry is divided into hospital only, hospital & corporation, corporation only, physician & corporation and physician & hospital. In 2019, the physician & hospital segment generated a revenue of more than USD 2.7 billion and is forecast to witness exponential growth over the analysis period.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4520

In terms of surgery type, the market is bifurcated into endoscopy, dental, obstetrics/gynecology, otolaryngology, orthopedic, ophthalmology, plastic surgery, cardiovascular, podiatry and neurology. The neurology surgery segment is estimated to amass over USD 3.9 billion by 2026. Neurovascular surgical procedures are in high demand owing to progressive advancements in minimally invasive technologies and the trend is likely to continue over the analysis timeframe.

Speaking in terms of specialty type, the market is divided into single specialty and multi-specialty. In 2019, multi-specialty segment generated a revenue of over USD 12 billion. Such massive revenue collection can be attributed to the diversified number of services offered by multi-specialty ambulatory surgical centers, which is gaining consumer attention.

Browse report summary @ https://www.gminsights.com/industry-analysis/us-ambulatory-surgical-centers-market

Service-wise, U.S. ambulatory surgical centers industry is segmented into diagnosis and treatment. In 2019, the diagnosis segment accumulated gains more than USD 7 billion. Growing prevalence of chronic conditions, such as cancer and cardiovascular diseases has created a surmounting need for effective disease diagnosing tools. Shifting preference towards ambulatory surgical centers owing to its cost-effectiveness in comparison to the hospital may further stimulate segmental growth.

Key players operating in U.S. ambulatory surgical centers industry are ASD Management, HCA Healthcare, Constitution Surgery Alliance,  Covenant Surgical Partners (KKR), Ambulatory Surgical Centres of America, Envision Healthcare Solution, Medical Facilities Corporation, Foundation Healthcare, Nuehealth Enterprises, Proliance Surgeons, Elite surgical affiliates,  Physicians Endoscopy,  Regent Surgical Health, Surgical Care Affiliates, Surgery Partners, SurgCenter Development, Tenet Healthcare, and Surgical Management Professionals.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Speedy legalization of medical marijuana across a number of states in the U.S. is likely to drive U.S. cannabis testing market outlook. In recent years, the efficacy of cannabis in treating diseases such as epilepsy and chronic pain has come to light. Positive effects of medical cannabis in treating lethal diseases has prompted the government to relax the regulatory spectrum on cannabis, which is likely to transform the industry landscape. Constant efforts of regulatory authorities to ensure consumer safety and enhance product quality is impelling the growth of cannabis testing laboratories. In 2019, testing laboratories accounted for revenue generation of over USD 492.5 million in the U.S. cannabis industry share.

Moreover, growing need for accurate labelling of marijuana content in various products will also boost industry growth. As per estimates, U.S. cannabis testing market is likely to cross the USD 1.2 billion mark by 2026.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4481

Increased awareness pertaining to cannabis’ medical benefits

Cannabis has been approved as an effective treatment for a wide assortment of ailments, such as cancer, epilepsy, chronic pain, stress disorder, etc. Increasing use of cannabis for medical application in an array of diseases has prompted research institutes to further focus upon discovering additional applications of cannabis. Moreover, increasing investment in research and development of cannabis products may expand cannabis testing industry size over the coming years.

Upon realizing the medical benefits of marijuana, various U.S. states have legalized the use of marijuana for certain medical conditions. This legalization has drastically increased the need for laboratories to test for safety and potency of drugs utilizing cannabis.

Also, growing consumer awareness pertaining to medical benefits of marijuana will increase the number of users, which will further create the need to ensure safety standards of products.  This may further create feasible conditions for the expansion of U.S. cannabis testing industry.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4481

Growing need for cannabis potency testing

Cannabis potency testing is necessary as it allows consumers to make informed purchasing decisions based on the composition and strength of cannabis products. Cannabis products vary widely in their potency and accurate testing becomes even more crucial as patients are using cannabis as a medical drug.

Potency testing involves analyzing the product for concentration of compounds such as  cannabidiol (CBD) and tetrahydrocannabinol (THC), which are proven to have medical benefits. The testing is then used to accurately label products for dosage, to optimize the potency of crops and obtain certification for the same. In 2019, potency testing held a significant market share and is expected to grow at 10.7% CAGR over the analysis period.

Such massive growth can also be attributed to surge in number of medical marijuana cultivators. With growing competition in the market, industry players are also focusing upon producing increasingly potent products.

Browse report summary @ https://www.gminsights.com/industry-analysis/us-cannabis-testing-market

Legalization of cannabis

Legalization of cannabis across various states in the U.S has positively impacted cannabis testing industry outlook. In 2019, mountain states in the U.S accounted for USD 167.4 million in the global share. Such impeccable growth can be attributed to the presence of states such as Colorado, Nevada and New Mexico in the region, where the use of cannabis as a therapeutic drug has been approved. Medical marijuana industry is rapidly expanding with the legalization of marijuana, which will also fuel the growth of cannabis testing market.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/

Medical equipment financing market has been experiencing exponential growth over the years due to the need to provide precise, reliable, safe and cost-effective services to patients. Medical equipment financing assists hospital administrators and practitioners to carry out cash flow to address possible equipment reimbursement. Equipment financing helps in the purchase of various medical devices instead of leasing them.

Increasing incidences of chronic diseases such as cardiovascular diseases, tumors, and diabetes across the globe is propelling the demand for minimally invasive medical equipment that are reliable, fast and advanced. Moreover, constant upgradation in patient monitoring and diagnostic devices is driving the adoption of advanced medical devices in hospitals.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4515

As per the U.S. Department of Health and Human Services, in 2019, close to 6 in 10 adults suffered from serious illnesses such as Alzheimer's, diabetes, cancer, kidney and lung disease in the U.S. Evident rise in the discovery of new diseases and viruses is facilitating R&D in medical equipment to ensure targeted treatment for specific medical issues.

Equipment financing companies are meanwhile entering into strategic partnerships and acquisitions with an aim to expand their business profits. For instance, TimePayment acquired LeaseQ Inc. in April 2019. The business transaction added significance to the strategic focus of TimePayment and provided vendor partners a faster funding option, differentiated product offerings, and enhanced services.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4515

Initiatives undertaken by governments across the globe to provide affordable, safe, reliable and innovative healthcare services to the citizens is a primary factor magnifying medical equipment financing industry outlook. The Affordable Care Act in the United States has imposed the pressure of reimbursements on hospitals, encouraging them to adopt novel technologies and operate efficiently along with achieving economies of scale.

Additionally, the act is building competitive pressure among the medical facilities which leads to increased expenditure on advanced technologies. Hospitals these days are aiming at increasing their cash reserves in order to purchase needed medical devices and to address its necessary reimbursements.

Ambulatory surgical centers are witnessing widespread popularity over the years owing to offered benefits such as personalized care, reduction in patient wait time and lowered cost of carrying out surgery. An increase in the number of ambulatory surgical centers creates the need for medical equipment required to carry out surgeries.

Browse report summary @ https://www.gminsights.com/industry-analysis/medical-equipment-financing-market

High geriatric population in China along with adequate awareness among people regarding healthy living will positively influence medical equipment financing market size in the region. It is estimated that, over 2020-2026, China medical equipment financing market share may register notable CAGR of 9.2%. Establishment of favorable policies along with heavy investments made by the government towards the development in healthcare sector may bolster industry trends.

With respect to equipment, the medical equipment financing market is bifurcated into patient monitoring, diagnostic, therapeutic, medical furniture, and laboratory. Diagnostics equipment are an extremely important tool that identifies microorganisms causing infection and helps perform the most appropriate treatments.

The diagnostic equipment industry is extensively working towards enhancing the clinical outcomes along with precise information regarding cause of an illness. Frequent innovations in the diagnostic equipment market owing to the discovery of diseases is encouraging doctors to undertake financial help from banks or other financial institutions to buy advanced diagnostic tools. 

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/

As per a research report by Global Market Insights, Inc., global pharmacovigilance market is estimated to surpass $8.9 billion by 2025. 

With growing consumption of drugs and rising concerns regarding adverse effects of drugs across the world, the global pharmacovigilance market size is projected to witness a lucrative rate of growth over the forthcoming time period. Factors such as growing accessibility to drugs, increasing number of chronic diseases and rising per capita healthcare expenditure in several countries across the world will further impact the industry growth.

As per reports presented by the CDC (Centers for Disease Control and Prevention), in 2017, approximately 28,000 deaths occurred owing to synthetic opioids consumption in the United States.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/853

Meanwhile, use of personalized medicines has also increased profoundly, especially in developed nations. Additionally, the adoption of gene therapy for treating various types of cancer and other chronic diseases, has further led to demand for personalized medicines over the forthcoming years.

Advancements in precision as well as personalized medicine are further anticipated to offer solutions to individuals by taking into consideration their reactions to medicine and composition of genes. Innovations as well as growing acceptance of personalized medicine will likely surge the need for pharmacovigilance practices further.

 The clinical trial phases segment is bifurcated into phase IV, phase III, phase II, phase I, and preclinical studies. The phase IV segment accounted a revenue share of over 70% in 2018. Pharmacovigilance is crucial for safety surveillance after the drug has been released in the market.

Pharmacovigilance detects and further reports harmful effects along with adverse drug reactions (ADRs), which may result in restricted use in certain patients or even discontinuation of drugs. Hence, increasing number of pharmaceutical companies focused towards new drug development will lay a positive impact in the market.

With respect to service providers, the segment is divided into contract outsourcing and in-house. Among these, in 2018, the in-house services segment accounted for a revenue share of 45%, it is likely to grow significantly over the projected time frame.  The preference for these services is likely to increase due to concerns regarding confidentiality and data safety.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/853

Furthermore, segmental growth can also be fueled by companies having developed infrastructure as well as skilled staff.

On the geographical front, the Europe pharmacovigilance market is expected to witnessed a CAGR of 9.5% during the forecast timeline. Practices such as harmonization and centralization of pharmacovigilance will further prove to be effective for the observation of safety signals in the region.

Moreover, since 2012, rules imposed in the EU, have led to increased involvement of patients and professionals in the PRAC (Pharmacovigilance and Risk Assessment Committee). Furthermore, advancements in personalized medicines are further set to offer numerous opportunities for the growth of regional market.

Browse report summary @ https://www.gminsights.com/industry-analysis/pharmacovigilance-market

All in all, the above-mentioned determinants are likely to offer a diverse array of growth opportunities for global pharmacovigilance market players. The competitive landscape of global pharmacovigilance market includes companies like IQVIA, F. Hoffmann-La Roche Ltd, ICON, Cognizant, Clinquest Group, Infosys Ltd, Ecron Acunova Ltd, HCL Technologies, Boehringer Ingelheim, GlaxoSmithKline, Bristol-Myers Squibb, Accenture and IBM Corporation among others.

Moreover, implementation of strategies such as new product launch, acquisitions and mergers is quite active among the companies in the market space as they work to sustain their respective positions.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Global surrogacy market has emerged as one of the most remunerative verticals in recent years. Going forward, the industry is set to observe significant growth through 2025. A surge in the number of people suffering from infertility issues is likely to be a major factor pushing the market growth in the forthcoming years. Factors like stress, steroid usage, hormonal changes, and others would positively outline market growth as they actively contribute to infertility issues.

As a byproduct of rising infertility problems, growing awareness among people about infertility treatment coupled with increasing number of fertility clinics would majorly drive the market demand in the future. Meanwhile, various technological advancements in the field of assisted reproductive technologies would add up to industry development.

According to a research report by Global Market Insights, Inc., global surrogacy market is estimated to surpass $27.5 billion through 2025.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4469

The increasing number of infertility cases and heavy adoption of in-vitro fertilization services is driving the demand for the in-vitro fertilization segment. The segment accounted for more than 60% share in 2018. In addition, the increasing tendency of women freezing eggs to give birth to a child in later stages would augment the segment share in the coming years.   

With reference to the service provider segment, fertility clinics are anticipated to observe heavy growth trends in the coming years. The segment is projected to reach up to $17.7 billion through 2025. Mounting awareness regarding infertility treatments available and the surging number of fertility specialists and centers would majorly outline the segment growth.

In addition, growing disposable income of people across the world along with rising healthcare expenditure would positively impel the segment share in the surrogacy market.

With respect to the surrogacy type segment, gestational surrogacy is projected to observe heavy profits in the coming years. The segment also dominated the market share in 2018. It is projected to grow by more than 24.8% through the forecast timespan.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4469

Increasing technological advancements in the field is a major factor pushing the segment growth in the overall market. Heavy adoption of gestational surrogacy by professionals would critically outline the market share in the forthcoming years.

In fact, legal and emotional complexities that come with traditional surrogacy have further pushed the growth of the gestational surrogacy segment driving the overall industry outlook.  

Meanwhile, 38-39 years age group segment will majorly propel the market share. The segment is likely to grow at a CAGR of more than 24% during the forecast timespan. Rising number of women having fertility problems that further result in various issues in getting pregnant or sustaining pregnancy is a major growth factor of the segment. The fertility rate across developed economies is generally low owing to easily available birth control measures, economic affluence and lifestyle choices of people.

Browse report summary @ https://www.gminsights.com/industry-analysis/surrogacy-market

All in all, factors such as growing infertility issues, and increasing preference of gestational surrogacy among others are overtly indicative of massive opportunities for surrogacy market players. Some of the prominent industry players operating in the market are Bangkok IVF Center, Extraordinary Conceptions, AVA Clinic Scanfert, IVI-RMA GLOBAL, Ovation Fertility, New Hope Fertility Center, and Nova IVI Fertility (NIF) among others.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

A research study conducted by Global Market Insights, Inc., predicts that cardiac ablation market size is expected to surpass $6.5 billion by 2026.

Rising prevalence of cardiovascular diseases (CVDs) and increasing pace of population aging are offering momentum to the growth of cardiac ablation market size. Escalating cognizance regarding advanced therapies for CVDs has led to widespread adoption of cardiac ablation as a treatment modality. In addition, rise in number of patients with atrial fibrillation globally is likely to push the growth of cardiac ablation industry.

Request for a Sample of this research report: https://www.gminsights.com/request-sample/detail/3702

A few major trends fostering cardiac ablation industry growth are as follows:

Growing incidence of CVDs

Demand for cardiac ablation procedure is likely to mount owing to increasing cases of cardiovascular diseases and expanding geriatric population pool. As per the Centers for Disease Control and Prevention, one death happens every second due to some type of cardiovascular disease in the U.S. Drug therapy solely cannot alleviate certain disorders and require cardiac ablation for quicker recovery and better results. Heightening adoption of advanced treatment procedures will augment cardiac ablation market size in the ensuing years.

Towering adoption in ambulatory surgical centers

Cardiac ablation market is likely to accumulate considerable proceeds from ambulatory surgical centers. Patients are increasingly opting for cardiac ablation procedure in ambulatory surgical centers on account of the availability of expert healthcare professionals, improving quality of healthcare services, short procedure length, and cost-effectiveness offered by these healthcare centers. Advancing healthcare infrastructure and easy accessibility of ambulatory surgical centers, especially in developed economies will remarkably stimulate cardiac ablation market trends.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3702

Intensifying demand for ultrasound ablators

Among the various types of ablators, such as radiofrequency, ultrasound, cryoablation, and others, ultrasound ablators are witnessing substantial demand. These devices are being extensively used for intracardiac visualization of cardiac physiology due to their easy-to-use feature and cost-effectiveness. Rise in awareness about the benefits of ultrasound ablators and increasing expenditure on healthcare will accelerate product adoption. The ultrasound ablators segment is likely to register a 14% CAGR over 2020-2026.

Increasing cases of cardiovascular disorders in Germany

Incidents of cardiovascular diseases in Germany are increasing at a high rate. People are becoming more aware about the availability of advanced medical facilities for effective treatment of such diseases. Germany is one of the economically and technologically developed countries with the presence of several major cardiac ablation industry players. The regional industry players are endeavoring to expand their geographical footprints by acquiring domestic firms, which will offer expeditious growth opportunities to cardiac ablation market. Germany cardiac ablation industry is slated to record a 12.7% CAGR over the forecast period.

Browse Report Summary: https://www.gminsights.com/industry-analysis/cardiac-ablation-market

Technological innovations and partnerships to define the strategic roadmap

Cardiac ablation market participants are pursuing various business strategies, such as product innovations, collaborations, mergers to strengthen their foothold in the market. For instance, in April 2018, MicroPort Scientific Corporation acquired cardiac rhythm management arm of LivaNova to extend its cardiovascular portfolio. The acquisition helped the company reinforce its presence in the electrophysiology industry.

Another instance of similar efforts is the acquisition of EPIX Therapeutics, Inc. by Medtronic. The acquisition was aimed at accelerating the development of treatment for cardiac arrhythmias in the near future. Some notable industry players operating in cardiac ablation market are Boston Scientific Corporation, Stereotaxis, Inc., and Abbott Laboratories (St. Jude Medical) among other players.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com